EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Actinomycetoma in a patient with pre-existing sensorineural hearing loss: a linezolid-based treatment paradigm

Kirti Deo, Priya Garg, Anuja Masare, Shubham Vijay Deokar

BMJ Case Reports · 2024

DOI: 10.1136/bcr-2023-258686 ↗

Kurz gefasst

Fallbericht in der Zeitschrift BMJ Case Reports, 2024. Verfasst von Kirti Deo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, Dr D Y Patil Vidyapeeth, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Linezolid, Hearing Loss, Sensorineural, Mycetoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycetoma is a chronic granulomatous infectious disease with a triad of subcutaneous swelling, discharging sinuses and the presence of granules. The infection may occur following minor trauma or penetrating thorn injury. We report a case of a man in his 40s with a history of thorn prick 9 years ago, followed by the formation of painless discharging sinuses on the right foot for the past 2 years. Clinical, local epidemiological, histopathological examination and Gram stain confirmed the diagnosis of actinomycetoma. Prior to initiating the Welsh regimen, a pretreatment assessment of the patient’s auditory function was conducted through pure tone audiometry, indicating the existence of pre-existing high-frequency bilateral sensorineural hearing loss. The patient was treated with linezolid as an alternative to amikacin, at a dosage of 600 mg two times per day, leading to complete resolution within 3 weeks. This underscores linezolid’s efficacy as a safe and cost-effective alternative for actinomycetoma, without causing ototoxic side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidHearing Loss, SensorineuralMycetomaHumansMaleAdultAnti-Bacterial AgentsTreatment Outcome

Stichwörter der Autor:innen

DermatologyPharmacology and therapeuticsSkin

Substanzen

LinezolidAnti-Bacterial Agents

Autor:innen und Institutionen

  • Dermatology, Dr D Y Patil Vidyapeeth, Pune, Maharashtra, India.
  • Dermatology, Dr D Y Patil Vidyapeeth, Pune, Maharashtra, India priyagarg8889@gmail.com.

Zitieren

APA

Deo, K., Garg, P., Masare, A., & Deokar, S. V. (2024). Actinomycetoma in a patient with pre-existing sensorineural hearing loss: a linezolid-based treatment paradigm. BMJ Case Reports. https://doi.org/10.1136/bcr-2023-258686

Vancouver

Deo K, Garg P, Masare A, Deokar SV. Actinomycetoma in a patient with pre-existing sensorineural hearing loss: a linezolid-based treatment paradigm. BMJ Case Reports. 2024. doi:10.1136/bcr-2023-258686

BibTeX
@article{Deo2024,
  author = {Deo, Kirti and Garg, Priya and Masare, Anuja and Deokar, Shubham Vijay},
  title = {Actinomycetoma in a patient with pre-existing sensorineural hearing loss: a linezolid-based treatment paradigm},
  journal = {BMJ Case Reports},
  year = {2024},
  doi = {10.1136/bcr-2023-258686}
}
Kostenlos starten →